MISSIONPHARMA GROUP ApS — Credit Rating and Financial Key Figures

CVR number: 29782792

Vassingerødvej 9, 3540 Lynge

Income statement (mDKK)

	2018	2019	2020	2021	2022
Fiscal period length	12	12	12	12	12
Net sales	756.97	780.35	726.93	682.48	924.32
Purchases during the financial year	-85.63
Costs of manufacturing				- 384.92	- 571.60
External services	-38.73			- 164.06	- 123.38
Gross profit	27.81	99.25	182.24	133.50	229.34
Employee benefit expenses	-15.53			-55.64	-65.44
Total depreciation	-2.90			-8.84	-4.30
EBIT	9.37	99.25	182.24	69.02	159.60
Other financial income	1.46			1.50	3.93
Other financial expenses	-7.48			-1.23	-9.13
Pre-tax profit	31.60	16.98	78.07	69.29	154.40
Income taxes	1.31			-16.98	-35.14
Net earnings	32.92	16.98	78.07	52.30	119.26

	2018	2019	2020	2021	2022
Development expenditure					0.44
Intangible rights	3.97
Goodwill	27.49			1.87
Intangible assets total	31.46			1.87	0.44
Land and waters	28.43			24.29	24.90
Buildings				2.40	4.82
Machinery and equipment	6.19
Other tangible assets				19.55	18.42
Tangible assets total	34.62			46.24	48.14
Investments total	-37.06	407.60	454.88
Non-current loans receivable	17.57
Long term receivables total	17.57
Finished products/goods	109.93			98.95	111.48
Inventories total	109.93			98.95	111.48
Current trade debtors	199.11			55.27	62.23
Current amounts owed by group member comp.				162.30	212.39
Prepayments and accrued income	8.99			25.92	73.61
Current other receivables	27.85			10.25	4.56
Current deferred tax assets	15.57			11.01	12.26
Short term receivables total	251.52			264.74	365.05
Cash and bank deposits	16.86			30.43	25.04
Cash and cash equivalents	16.86			30.43	25.04
Balance sheet total (assets)	424.88	407.60	454.88	442.23	550.15

	2018	2019	2020	2021	2022
Share capital	0.13	285.06	348.43	0.13	0.13
Shares repurchased	56.20			90.00	150.00
Other reserves	-22.45			- 323.88	- 352.06
Other restricted equity				322.93	349.72
Retained earnings	230.02	-16.98	-78.07	181.45	82.68
Profit of the financial year	32.92	16.98	78.07	52.30	119.26
Minority interest (BS)	0.33			0.32	1.35
Shareholders equity total	297.15	285.06	348.43	323.25	351.07
Provisions	3.89
Non-current deferred tax liabilities				1.35	0.02
Non-current liabilities total				1.35	0.02
Current loans from credit institutions	58.13
Advances received	19.88			33.92	104.28
Current trade creditors	40.15			55.98	56.61
Other non-interest bearing current liabilities	20.30			27.73	38.16
Current liabilities total	138.46			117.63	199.06
Balance sheet total (liabilities)	439.50	285.06	348.43	442.23	550.15

Try the full version of our system for free

... and more!

No registration needed.